Jane Street
NPCE icon

Jane Street’s Neuropace NPCE Stock Holding History

Jane Street’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,200
Closed -$147K – 12627
2026
Q1 		$147K Buy
+11,200
New +$168K ﹤0.01% 10401
2025
Q3 		– Sell
-13,700
Closed -$153K – 11454
2025
Q2 		$153K Buy
+13,700
New +$171K ﹤0.01% 8735

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street's NPCE Position: Q2 2026 in Review

Jane Street increased its Neuropace (NPCE) stake by 23% in Q2 2026, buying an estimated $102K and bringing the position to 34,438 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #7798.

Jane Street first reported a position in NPCE in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.82M in Q4 2025. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Jane Street held 34,438 shares of Neuropace worth $547K as of Q2 2026.
  • Jane Street bought 6,346 Neuropace shares in Q2 2026, an estimated $102K.
  • Neuropace made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7798 holding.
  • Jane Street first reported a position in Neuropace in Q2 2021 and has held it in 7 quarters since.
  • Jane Street's Neuropace position peaked at $1.82M in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.